Studies of the chemical nature of the  -adrenergic receptor. V. Validity of the receptor protection approach.
D000317:Adrenergic alpha-Antagonists / Q000037:antagonists & inhibitors; D000818:Animals; D001011:Aorta / Q000378:metabolism; D002247:Carbon Isotopes; D003983:Dibenzylchlorethamine / Q000037:antagonists & inhibitors; D004837:Epinephrine / Q000008:administration & dosage / Q000494:pharmacology; D066298:In Vitro Techniques; D007259:Infrared Rays; D010643:Phenoxybenzamine / Q000378:metabolism; D011817:Rabbits; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D013057:Spectrum Analysis; D013997:Time Factors
D000317:Adrenergic alpha-Antagonists; D002247:Carbon Isotopes; D011941:Receptors, Adrenergic; D011955:Receptors, Drug; D010643:Phenoxybenzamine; D003983:Dibenzylchlorethamine; D004837:Epinephrine